Records containing: Hepatocellular Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-06-23Direct-acting Antiviral Therapy Decreases Hepatocellular Carcinoma Recurrence Rate in Cirrhotic Patients With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2017-06-23Hepatic Arterial Embolization of Hepatocellular Carcinoma With a Doxorubicin Eluting Bead
-
CLINICAL_TRIALS study record update · 2017-06-20The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
-
CLINICAL_TRIALS study record update · 2017-06-20The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
-
CLINICAL_TRIALS study record update · 2017-06-06Survival After Hepatectomy for Combined Hepatocellular Cholagiocarcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-06-01Filamin A Expression in HCC Patients
-
CLINICAL_TRIALS study record update · 2017-05-30Analysis of the Incidence of Expression of Tumor Antigens and Tumor Marker in Cancer Tissue From Asian Patients With Hepatocellular Carcinoma and Evaluation of Prognostic Significance of These Tumor Antigens.
-
CLINICAL_TRIALS study record update · 2017-05-25Evaluation of Performance of S-fusion for Radiofrequency Ablation of Hepatocellular Carcinoma: A Randomized, Prospective Study
-
CLINICAL_TRIALS study record update · 2017-05-16Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2017-05-15Apatinib Combined With Capecitabine Compared With Apatinib in the Treatment of Advanced Non-resectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2017-05-03A Phase II Randomized, Double-blinded, Multicenter Asian Study Investigating the Combination of Transcatheter Arterial Chemoembolization (TACE) and Oral Everolimus (RAD001, Afinitor®) in Localised Unresectable Hepatocellular Carcinoma (HCC) - The TRACER Study
-
CLINICAL_TRIALS study record update · 2017-05-01Phase II Randomized Trial Evaluating the Administration of Sorafenib or Pravastatin or Association Sorafenib-pravastatin or Best Supportive Care for the Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis
-
CLINICAL_TRIALS study record update · 2017-04-28A Randomization Trial of Adjuvant Lamivudine/ Adefovir Dipivoxil Against Recurrence in Post-operative HBV-related Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2017-04-26Validation of Questionnaire Module for Quality of Life and Analysis of Its Association With Clinical Outcomes; a Cohort Study in Patients With Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2017-04-26Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients
-
CLINICAL_TRIALS study record update · 2017-04-25ClinicalTrials.gov study NCT02725996
-
CLINICAL_TRIALS study record update · 2017-04-25Phase IB/II Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)
-
CLINICAL_TRIALS study record update · 2017-04-21A Phase I/II, Open Label Study to Evaluate the Safety and Efficacy of Autologous Cytokine-Induced Killer (CIK) Cell for Patients With Hepatocellular Carcinoma (HCC) After Transarterial Chemoembolization (TACE), Percutaneous Ethanol Injection Therapy (PEIT) or RadioFrequency Ablation (RFA) Therapy
-
CLINICAL_TRIALS study record update · 2017-04-19The Combination Effect of Statin Plus Metformin on Relapse-free
-
CLINICAL_TRIALS study record update · 2017-04-13Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients
-
CLINICAL_TRIALS study record update · 2017-04-12Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2017-04-12An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
-
CLINICAL_TRIALS study record update · 2017-03-29A Multicentre, Open Label, Phase I Trial in Japan of the MEK Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy
-
CLINICAL_TRIALS study record update · 2017-03-24A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2017-03-20Phase I Trial of Anti-GPC3 Chimeric T Cells for Subjects With GPC3-Positive Advanced Hepatocellular Carcinoma